Fintel reports that on January 17, 2025, Wedbush downgraded their outlook for Keros Therapeutics (NasdaqGM:KROS) from ...

Wedbush downgraded Keros Therapeutics (KROS) to Neutral from Outperform with a price target of $15, down from $47. The firm has removed ...

In a report released today, Jay McCanless from Wedbush reiterated a Hold rating on DR Horton (DHI – Research Report), with a price target of ...

UnitedHealth shares tumbled Thursday after the health insurer reported fourth-quarter results below Wall Street’s ...

Enphase Energy (ENPH) downgraded by Truist Securities, expecting growth headwinds and increased competition to impact stock performance in the near term.

Benzinga's options scanner spotted 14 options trades for Oklo. This is not a typical pattern. The sentiment among these major ...

U.S. stocks surged on Wednesday, with all three major indexes registering their biggest daily percentage gains in more than ...

Tesla is on track to possibly outperform the broader market in 2025, supported by compelling technical indicators.

Czech National Bank grew its position in McDonald’s Co. (NYSE:MCD – Free Report) by 6.3% during the 4th quarter, according to ...

Tesla (NASDAQ: TSLA) is a leading manufacturer of electric vehicles (EVs), whereas Meta Platforms (NASDAQ: META) is home to ...

Owens Corning (NYSE:OC – Get Free Report) had its price target lowered by stock analysts at Loop Capital from $215.00 to $210 ...

This year, Nvidia's biggest tailwind stems from its newest GPU lineup, known as Blackwell. With industry analysts calling for ...